Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 69,582 shares at $39.35 ($2.7M) on 2026-01-20, disclosed to the SEC on 2026-01-23.
Scheduled sale ($2.7M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.35 | 3,750 | $148K | 5.4% |
| 2 | $39.35 | 65,832 | $2.6M | 94.6% |
| Total | $39.35 avg | 69,582 | $2.7M | 100% |
| Filing → |
| RPRX | SELL | 2026-04-30 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |